Bill Gates, Carlos Slim, Spanish government announce $150M for health projects in Central America, Mexico

NewsGuard 100/100 Score

Bill Gates, co-founder of the Bill & Melinda Gates Foundation, and Carlos Slim, the "Mexican telecom magnate" and founder of the Carlos Slim Institute, announced Monday that they would work with Spain on a $150 million health initiative for people in Central America and Mexico, Agence France-Presse reports.

"Funds for the '2015 Meso-American Health Initiative' will be shared equally by the three contributors and will go over the next five years to improve maternal health, nutrition, vaccination, anti-dengue and anti-malaria campaigns in the region," the news service writes (6/14).

Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua and Panama will receive funding, BBC reports (6/15). According to Reuters, the program "will target indigenous communities - particularly women and children."  Reuters adds that the Inter-American Development Bank and local governments will oversee the initiative (Diaz/Rucker, 6/14).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.